Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

5.870 +0.090 (+1.56%)
Streaming Delayed Price Updated: 3:15 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
The Silent Architects: How Institutional Investors Shape Stock Performance and Market Destiny
Institutional investors, the colossal entities managing trillions in capital—from pension funds and mutual funds to hedge funds and endowments—are the often-unseen architects behind significant market... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
From Quanterix Corporation
Via Business Wire
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Preview: Quanterix
 
Via Benzinga
Earnings Scheduled For May 12, 2025
 
Via Benzinga
Earnings Outlook For Quanterix
 
Via Benzinga
Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Quanterix Releases Financial Results for the Second Quarter of 2025
From Quanterix Corporation
Via Business Wire
Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
From Quanterix Corporation
Via Business Wire
Quanterix Announces Cooperation Agreement with Kent Lake Capital
From Quanterix Corporation
Via Business Wire
Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
From Quanterix Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quanterix Corporation
Via Business Wire
Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
From Quanterix Corporation
Via Business Wire
Quanterix Expands Reach with IVD and Large Reference Labs
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Goldman Sachs Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Releases Financial Results for the First Quarter of 2025
From Quanterix Corporation
Via Business Wire
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
From Quanterix Corporation
Via Business Wire
Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders
From Kent Lake PR LLC
Via Business Wire
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
From Quanterix Corporation
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
From Kent Lake PR LLC
Via Business Wire
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya
From Kent Lake PR LLC
Via Business Wire
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
From Quanterix Corporation
Via Business Wire
Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Quanterix Releases Financial Results for the Fourth Quarter of 2024
From Quanterix Corporation
Via Business Wire
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call
From Kent Lake PR LLC
Via Business Wire
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
From Akoya Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.